LUX-Lung 8 试验的结果已在《柳叶刀肿瘤医学》上发布。LUX-Lung 8 是直接比较两款靶向 EGFR 治疗药物的最大规模前瞻性一对一 3 期试验。阿法替尼与厄洛替尼进行了对比，根据国际指...
LUX-Lung 8 test results of has in the Lancet Oncology ". LUX-Lung 8 is a direct comparison of the two targeted EGFR treatment of the largest prospective trial of one of the 3 trials. Afatinib and erlotinib were compared, according to means of international...
